Literature DB >> 10536260

Age-related changes in ultrastructural features of cathepsin B- and D-containing neurons in rat cerebral cortex.

H Jung1, E Y Lee, S I Lee.   

Abstract

The present study examines age-related changes in the subcellular localization of cathepsin B (cath B) and cathepsin D (cath D), as well as morphological features of the cathepsin-immunoreactive (ir) neurons in rat cerebral cortex. Sprague-Dawley rats were studied at 3 and 26 months. By immunoelectron microscopy cath B- or cath D-immunoreactivities were found in many, but not all, pyramidal neurons. In young rat cerebral cortical neurons, cath B was observed not only in lysosomal systems such as multivesicular bodies, dense bodies, and lipofuscin granules, but also in extralysosomal sites. By contrast, cath D was confined mainly to lysosomal systems in young rats. In aged rats, cath B showed a similar pattern in its subcellular localization compared to the young control, but some of the dense bodies containing cath B was closely apposed to the outer nuclear envelope. These cells exhibited a relatively normal appearance. Regardless of subcellular localization, approximately 10% of cath B-ir neurons displayed ultrastructural disturbances presumed to indicate an early stage of degeneration. The nucleus was indented, nuclear boundary was indistinct, nuclear pore structures appeared separately with high frequency, and the endoplasmic reticulum appeared to be affected. In addition to its presence in lysosomal structures, cath D-immunoreactivity in aged cerebral cortex was noted prominently in the cytosol as diffuse granules. About 37% of cath D-ir cells showed this age-related change. Among the neurons with the diffusely scattered form of cath D, approximately 70% of cells exhibited the degenerating features. These cells were characterized by large amounts of diffuse cath D, reduced cellular size, loss of the nuclear boundary, scattered nuclear pore structures, an often fragmentation of the nucleus, disturbances of endoplasmic reticular system, and in advanced stages, condensed nucleus and poor preservation of almost cytoplasmic organelles. Though some of these features were also found in cath B-ir neurons, findings of overt degeneration, such as fragmented and condensed nuclei and impaired almost cytoplasmic organelles, were generally not observed in cath B-ir neurons. In addition, lipofuscin aggregates containing cath D were observed frequently in the extracellular space close to sites of ruptured plasma membrane, whereas in the sections stained with anti-cath B antibodies, large-sized lipofuscin aggregates showed only very weak or no cath B-immunoreactivity at all. Taken together, the present results suggest that cath D and cath B may be regulated differently and play their specific roles in the aging of the brain, especially, the change in location of cath D from the lysosomal system to the cytosol in the aged brain may play an important role in age-related cell death.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10536260     DOI: 10.1016/s0006-8993(99)01888-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

Review 1.  Multivesicular bodies in neurons: distribution, protein content, and trafficking functions.

Authors:  Christopher S Von Bartheld; Amy L Altick
Journal:  Prog Neurobiol       Date:  2011-01-07       Impact factor: 11.685

2.  Up-regulation of cation-independent mannose 6-phosphate receptor and endosomal-lysosomal markers in surviving neurons after 192-IgG-saporin administrations into the adult rat brain.

Authors:  Cheryl Hawkes; Doreen Kabogo; Asha Amritraj; Satyabrata Kar
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

Review 3.  Cathepsin B Gene Knockout Improves Behavioral Deficits and Reduces Pathology in Models of Neurologic Disorders.

Authors:  Gregory Hook; Thomas Reinheckel; Junjun Ni; Zhou Wu; Mark Kindy; Christoph Peters; Vivian Hook
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

4.  Hydrogen peroxide induces lysosomal protease alterations in PC12 cells.

Authors:  Daniel C Lee; Ceceile W Mason; Carl B Goodman; Maurice S Holder; Otis W Kirksey; Tracy A Womble; Walter B Severs; Donald E Palm
Journal:  Neurochem Res       Date:  2007-04-18       Impact factor: 3.996

5.  Cystatin C has a dual role in post-traumatic brain injury recovery.

Authors:  Marina Martinez-Vargas; Maribel Soto-Nuñez; Erika Tabla-Ramon; Barbara Solis; Ruben Gonzalez-Rivera; Adan Perez-Arredondo; Francisco Estrada-Rojo; Andres Castell; Juan Molina-Guarneros; Luz Navarro
Journal:  Int J Mol Sci       Date:  2014-04-04       Impact factor: 5.923

Review 6.  An Overview of the Role of Lipofuscin in Age-Related Neurodegeneration.

Authors:  Alexandra Moreno-García; Alejandra Kun; Olga Calero; Miguel Medina; Miguel Calero
Journal:  Front Neurosci       Date:  2018-07-05       Impact factor: 4.677

7.  ATP13A2 missense variant in Australian Cattle Dogs with late onset neuronal ceroid lipofuscinosis.

Authors:  Isabelle Schmutz; Vidhya Jagannathan; Florian Bartenschlager; Veronika M Stein; Achim D Gruber; Tosso Leeb; Martin L Katz
Journal:  Mol Genet Metab       Date:  2019-03-27       Impact factor: 4.797

Review 8.  The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management.

Authors:  Tulasi Yadati; Tom Houben; Albert Bitorina; Ronit Shiri-Sverdlov
Journal:  Cells       Date:  2020-07-13       Impact factor: 6.600

9.  Adenosine A1 Receptor Agonist (R-PIA) before Pilocarpine Modulates Pro- and Anti-Apoptotic Factors in an Animal Model of Epilepsy.

Authors:  Daniele Suzete Persike; Rebeca Padrão Amorim Puccinelli; Maria José da Silva Fernandes
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-18

Review 10.  Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate.

Authors:  Gregory Hook; J Steven Jacobsen; Kenneth Grabstein; Mark Kindy; Vivian Hook
Journal:  Front Neurol       Date:  2015-09-02       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.